Hormonal therapy for estrogen receptor positive (ER+) breast cancer
Hormonal therapy is a type of treatment that is used to treat hormone receptor positive breast cancer. This type of cancer is the most common type of breast cancer, as it grows in response to hormones such as estrogen. Hormonal therapy works by blocking the effects of hormones on cancer cells, which can slow down or stop their growth.
There are several different types of hormonal therapy that are used to treat ER+ breast cancer. The most commonly used types of hormonal therapy are:
1. Selective estrogen receptor modulators (SERMs) - These drugs, such as Tamoxifen, work by blocking the effects of estrogen on breast cancer cells. They are usually taken for 5-10 years.
2. Aromatase inhibitors - These drugs, such as Letrozole and Anastrozole, work by blocking the production of estrogen in the body. They are usually taken for 5-10 years.
3. Fulvestrant - This drug works by binding to estrogen receptors and blocking them from signaling to cancer cells. It is usually given as an injection once a month.
4. GnRH agonists - These drugs, such as Goserelin and Leuprolide, work by suppressing the production of estrogen in the ovaries. They are usually given as an injection once every 3 months.
Hormonal therapy can be used alone or in combination with other treatments, such as chemotherapy or radiation therapy. The choice of treatment depends on several factors, including the stage and aggressiveness of the cancer, the patient’s age and overall health, and the presence of other health conditions.
Hormonal therapy is generally well tolerated, with few side effects. Some common side effects include hot flashes, night sweats, vaginal dryness, and joint pain. Rare but serious side effects include blood clots, stroke, and endometrial cancer (in women who still have their uterus).
It is important to note that hormonal therapy is not a cure for breast cancer, but it can greatly reduce the risk of the cancer coming back. Therefore, it is important for patients to continue taking their hormonal therapy for the recommended length of time, even if they feel well.
In conclusion, hormonal therapy is an important treatment option for women with ER+ breast cancer. It works by blocking the effects of hormones on cancer cells, which can slow down or stop their growth. There are several different types of hormonal therapy available, and the choice of treatment depends on several factors. Hormonal therapy is generally well tolerated, with few side effects, but it is important for patients to continue taking their treatment for the recommended length of time. With proper treatment and care, many women with breast cancer are able to live long and healthy lives.